A microemulsion co-loaded with Schizandrin A–docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance

Multidrug resistance (MDR) is the major underlying cause of the low 5-year survival rate of esophageal carcinoma. In this study, we developed a novel microemulsion system (SD-ME) co-loaded with docetaxel (DTX) and Schizandrin A, a potent chemotherapeutic agent and a potential drug resistance modulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xiangyu, Gao, Chanchan, Shi, Fangfang, Feng, Xiaoyao, Liu, Lin, Qu, Ding, Wang, Cailian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241110/
https://www.ncbi.nlm.nih.gov/pubmed/28155336
http://dx.doi.org/10.1080/10717544.2016.1225854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241110/
https://www.ncbi.nlm.nih.gov/pubmed/28155336
http://dx.doi.org/10.1080/10717544.2016.1225854

Ejemplares similares